Methylene blue-encapsulated phosphonate-terminated silica nanoparticles for simultaneous in vivo imaging and photodynamic therapy. (2009)

Peer-Reviewed Study · He X; Wu X; Wang K; Shi B; Hai L · October 2009

He X et al., 2009-10: Study of methylene blue encapsulated in silica nanoparticles, reporting photodynamic damage to HeLa cells at 635 nm and an antitumour PDT effect on a xenograft tumour in mice, alongside in vivo imaging.

And the effect of the PDT toward the xenograft tumor in vivo is exciting after imaging the MB-encapsulated PSiNPs injected tumor using in vivo optical imaging system.

He X et al., 2009-10: Study of methylene blue encapsulated in silica nanoparticles, reporting photodynamic damage to HeLa cells at 635 nm and an antitumour PDT effect on a xenograft tumour in mice, alongside in vivo imaging. C5 He 2009. Study type: in vitro plus in vivo xenograft (mouse). N, dose, light dose: not stated in the abstract. Country: China. Funder: 'Research Support, Non-U.S. Gov't'. Comparator: not stated in the abstract. Confidence MEDIUM because the abstract asserts the xenograft effect without numbers ('exciting'), so no size or regression figure can be quoted. Agent is a nanoparticle formulation.